Alpha 1-antitrypsin deficiency: Difference between revisions
No edit summary |
Mazia Fatima (talk | contribs) No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Mazia}} | {{CMG}}; {{AE}} {{Mazia}} | ||
{{SK}}: | {{SK}}: Alpha-1-deficiency; Anti-protease deficiency; | ||
'''For patient information, click [[Alpha 1-antitrypsin deficiency (patient information)|here]]''' | '''For patient information, click [[Alpha 1-antitrypsin deficiency (patient information)|here]]''' |
Latest revision as of 14:24, 11 January 2018
Alpha 1-antitrypsin deficiency Microchapters |
Differentiating Alpha 1-antitrypsin deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Alpha 1-antitrypsin deficiency On the Web |
American Roentgen Ray Society Images of Alpha 1-antitrypsin deficiency |
Directions to Hospitals Treating Alpha 1-antitrypsin deficiency |
Risk calculators and risk factors for Alpha 1-antitrypsin deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]
Synonyms and keywords:: Alpha-1-deficiency; Anti-protease deficiency;
For patient information, click here Template:DiseaseDisorder infobox
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Alpha 1-antitrypsin deficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies